Table 3: ART use by clinical characteristics.
ART use prior to ICU admission | ART use during ICU stay | |||||||
Yes N = 104 |
No N = 121 |
p-value | ARV discontinued N = 45 |
ARV initiated N = 10 |
ART continued N = 54 |
No ART Usea N = 129 |
p-value | |
CD4 (Median (IRb)) | 179.0 (348) | 43 (254) | 0.000 | 181 (844) | 10 (417) | 201 (538) | 45 (763) | < 0.05 |
Length of stay (Median (IR) | 3.0 (6.0) | 3.0 (65.0) | 0.140 | 3.0 (6.0) | 3.50 (35.0) | 3.0 (6.0) | 3.0 (5.0) | 0.561 |
APACHE II score (Mean ± SD) | 16.9 ± 9 | 15.3 ± 11 | 0.210 | 19 ± 9.3 | 14.4 ± 4.8 | 15.0 ± 6.9 | 16.6 ± 9.4 | 0.206 |
AIDS defining diagnosis (%)
Yes No |
30.0 55.7 |
70.0 47.3 |
0.02 |
9.6 23.4 |
7.72.8 |
15.4 29.0 |
67.3 44.8 |
0.006 |
Co-morbidities ( %Yes) Psychiatric disorders Cardiovascular disorder Hepatic disorders Renal disorders Respiratory disorders Neurological disorders Endocrine disorders Substance abuse |
40.0 51.5 48.5 52.5 46.3 52.6 41.9 43.7 |
60.0 48.5 51.5 57.5 56.7 47.4 58.1 56.3 |
0.439 0.139 0.627 0.235 0.959 0.543 0.546 0.635 |
10.8 21.8 22.5 18.5 18.6 28.6 25.0 19.2 |
0.0 3.0 4.2 7.7 2.3 4.8 0.0 5.1 |
24.3 27.7 23.9 30.8 25.6 19.0 18.2 17.9 |
64.9 47.5 49.3 43.1 53.5 47.6 56.8 57.7 |
0.222 0.201 0.765 0.070 0.889 0.695 0.274 0.633 |
ICU admission diagnosis (%) AMS Respiratory/Pneumonia Gastrointestinal Sepsis/Shock Cardiovascular related Metabolic disturbances Liver failure Renal failure |
36.4 44.9 27.8 50.0 56.5 53.8 75.0 25.0 |
63.6 55.1 72.2 50.0 43.5 46.2 25.5 75.0 |
0.329 0.767 0.102 0.695 0.296 0.570 0.338 0.626 |
21.7 16.9 16.7 11.5 12.5 38.5 50.0 0.0 |
4.3 3.6 5.6 7.7 4.2 7.7 0.0 0.0 |
17.4 20.5 11.1 23.1 41.7 23.1 25.0 25.0 |
56.5 59.0 66.7 57.7 41.7 30.8 25.0 75.0 |
0.930 0.751 0.605 0.625 0.133 0.206 0.407 0.735 |
Mortality in the ICU (%) Survived Died |
45.4 51.3 |
54.6 48.7 |
0.596 |
17.8 24.0 |
4.3 4.0 |
24.9 14.0 |
53.0 58.0 |
0.386 |
aThese were defined as patients who came in without ART and did not receive any ART while in the ICU; bIR = Interquartile range.